ResMed Inc.
RMD
$245.73
-$13.29-5.13%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.64% | -8.21% | 4.02% | 5.93% | 10.68% |
| Total Depreciation and Amortization | 9.11% | -24.54% | 48.84% | -7.78% | 4.76% |
| Total Amortization of Deferred Charges | -0.11% | 0.90% | 1.31% | -2.22% | -0.87% |
| Total Other Non-Cash Items | 4.86% | -0.60% | -11.60% | 27.98% | 15.71% |
| Change in Net Operating Assets | -663.43% | -57.02% | -55.58% | 215.13% | -93.43% |
| Cash from Operations | -25.71% | -15.12% | -6.89% | 87.50% | -5.20% |
| Capital Expenditure | 33.58% | -40.48% | -47.07% | -0.74% | -15.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 99.62% | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -146.43% | -125.64% | 422.57% | 28.53% | -176.94% |
| Cash from Investing | 3.11% | 60.68% | -320.67% | 13.37% | -1,809.79% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 83.33% |
| Issuance of Common Stock | 260.23% | -72.79% | 234.21% | -66.43% | 220.61% |
| Repurchase of Common Stock | -29.58% | -49.83% | -33.44% | 17.80% | -82.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.19% | -13.09% | 0.15% | -0.01% | 0.25% |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -12.19% | -40.51% | -13.75% | 2.35% | 2.14% |
| Foreign Exchange rate Adjustments | 3,997.18% | -100.20% | 346.73% | 127.64% | -360.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.95% | -36.98% | -32.63% | 329.75% | -49.16% |